Kidney Donor Requirements: Complete Eligibility Guide

Kidney donor requirements are the medical, surgical, psychological, immunological and legal standards used to decide whether a person can safely donate one kidney while alive. A potential donor generally needs adequate kidney function, acceptable long-term health risk, suitable kidney anatomy, appropriate infection and cancer screening, the capacity to give voluntary informed consent and a complete evaluation by an authorized transplant team.

A willing donor is not automatically an approved donor. Even when the potential donor is a close family member and appears completely healthy, living donation requires much more than checking blood type or serum creatinine. The transplant team must consider what donation could mean for that person's health not only during surgery, but years and potentially decades afterward.

For a patient exploring a kidney transplant, understanding the donor evaluation early can prevent one of the most common planning problems: assuming that a relative or spouse has already “qualified” before the transplant center has reviewed the complete case.

International guidelines increasingly favor individualized assessment rather than rigid decision-making from one risk factor. KDIGO's living kidney donor guideline specifically recommends evaluating a candidate's overall demographic and health profile when estimating long-term kidney risk.

Kidney donor requirements: the direct answer

Kidney donor requirements generally include being medically fit for major surgery, having adequate kidney function and acceptable long-term kidney risk, completing blood and urine tests, blood-pressure and metabolic assessment, kidney imaging, infection and cancer screening, psychological evaluation and donor-recipient compatibility testing. The potential donor must also satisfy the legal requirements governing living donation in the country where transplantation will occur. No single blood test, blood type or online questionnaire can confirm eligibility. Final donor acceptance is made by the transplant program after the medical, surgical, psychosocial, immunological and, when applicable, legal evaluation has been completed.

Who can donate a kidney?

The question who can donate a kidney sounds simple, but there is no single universal profile.

A living kidney donor is usually an adult who can understand the consequences of donation, is voluntarily willing to proceed, has an acceptably low risk from surgery, has sufficiently healthy kidneys and is not expected to face an unacceptable long-term health risk after losing renal mass.

Potential donors may include parents, adult children, siblings, other relatives, spouses, partners or other people permitted under the applicable national legal framework. Relationship rules vary significantly between countries, which becomes particularly important when a patient is considering transplantation outside their country of residence.

In the United Kingdom, NHS Blood and Transplant explains that living kidney donors are often relatives, partners or close friends. Potential donors undergo a series of tests to assess general health, heart and lung health and kidney function. The donor is not accepted when the transplant team considers the health risk too serious.

Being related does not guarantee suitability.

For example, a sister may be emotionally willing to donate to her brother and may have a compatible blood group, yet have early evidence of kidney disease that makes donation inappropriate. Conversely, a spouse who is not genetically related may have excellent kidney health and potentially suitable compatibility.

This distinction matters because family members sometimes use “donor” and “potential donor” interchangeably. From a medical-planning perspective, it is safer to think of the person as a potential living donor until the formal evaluation has been completed.

Patients who are still learning how transplantation fits into the broader treatment pathway can also review our organ transplant procedures overview before comparing donor pathways.

Kidney donation requirements at a glance

Kidney donation requirements are best understood as several separate eligibility gates rather than one pass-or-fail blood test.

A donor does not need to be “perfect.” Modern evaluation recognizes that adults can have minor health findings without necessarily being excluded.

The important question is whether the combination of findings produces an acceptable lifetime risk.

This is one reason transplant centers can occasionally reach different conclusions about borderline candidates while still following responsible medical practice.

Living kidney donor requirements are primarily about donor safety

The central principle behind living kidney donor requirements is different from ordinary surgery.

Most operations are performed because the patient receiving the operation expects a direct medical benefit. Living donor nephrectomy is different: a healthy person undergoes surgery primarily to benefit another person.

That creates an especially high duty to identify avoidable risk before surgery.

The assessment therefore looks for both obvious disease and hidden risk. A potential donor may feel well, exercise regularly and have no symptoms while still having hypertension, albuminuria, reduced kidney reserve, an inherited renal condition or another finding that matters when one kidney is going to be removed.

The evaluation also considers the donor's age and expected future health. A health factor that creates modest short-term concern can be more important when its consequences could accumulate over 30 or 40 years.

KDIGO therefore promotes an integrated risk framework. Instead of asking only, “Is the blood pressure acceptable?” or “Is the GFR acceptable?”, the transplant team considers how age, kidney function, albuminuria, blood pressure, metabolic factors and other characteristics interact.

That approach is particularly important for international patients. A low-quality pathway may focus primarily on whether the recipient can undergo transplantation. A high-quality pathway evaluates the potential donor independently and treats donor protection as a core clinical objective.

Requirements for donating kidney: what the evaluation actually checks

People searching for the requirements for donating kidney often expect a short checklist such as “healthy, compatible and under a certain age.”

In reality, donor evaluation usually progresses from broad screening toward increasingly detailed testing.

Initial screening may identify obvious issues before more complex investigations are arranged. The team then reviews medical history, family history, medications, blood pressure, kidney function and laboratory results. Compatibility testing and detailed kidney imaging follow according to the center's protocol.

Current OPTN Policy 14 requires U.S. living kidney donor evaluations to include metabolic testing, urinalysis or urine microscopy, protein and albumin assessment, kidney-function measurement, inherited-kidney-disease protocols where indicated by family history and anatomical assessment of the kidneys. The policy also specifies additional evaluation when there is a history of kidney stones.

The exact sequence is not internationally identical, but the core objectives are similar.

This is why the answer to “Can my brother donate?” is rarely available from one laboratory report sent through WhatsApp or email.

The first useful step is a structured medical-record review, followed by the formal evaluation required by the transplant center.

Kidney living donor requirements for kidney function

Among all kidney living donor requirements, kidney function receives particular attention because donation permanently reduces the donor's renal mass.

Serum creatinine alone is not sufficient.

A creatinine result can look normal even when kidney filtration needs closer investigation. Creatinine is influenced by factors such as muscle mass, which is why donor assessment generally expresses renal function using estimated or measured glomerular filtration rate.

KDIGO recommends initial assessment using estimated GFR from serum creatinine and confirmation using an appropriate method when necessary. Its guideline gives practical GFR thresholds that are widely cited in donor evaluation.

These thresholds are not a home eligibility calculator.

A GFR of 88 does not automatically mean “approved,” and a result should be interpreted in relation to age, urine albumin, blood pressure, family history and other risk factors.

A transplant center may repeat kidney-function testing or use a more accurate confirmatory method if the first estimate is uncertain.

Why kidney reserve matters

A healthy person can live with one functioning kidney because the remaining kidney adapts after nephrectomy. That biological adaptation is well established, but it does not mean the donor retains exactly the same renal reserve they had with two kidneys.

This is why transplant programs aim to select potential donors who are expected to maintain safe kidney function over the long term.

The assessment is therefore more conservative than a routine annual check-up.

A laboratory report may classify someone's kidney function as acceptable for normal daily life while a donor team may still decide that the expected post-donation reserve is not sufficient.

Those are not contradictory judgments. They answer different questions.

Urine testing: an important part of living kidney donor requirements

Kidney disease can sometimes be detected through urine abnormalities before a person has symptoms.

Urine testing is therefore a routine part of living kidney donor requirements.

The assessment commonly looks for albumin or protein, microscopic blood, infection and other abnormalities.

Albumin in the urine matters because it can be a marker of kidney damage even when estimated GFR remains relatively preserved.

KDIGO recommends measuring albuminuria rather than relying only on total urinary protein when assessing donor candidates. The guideline considers albumin excretion below 30 mg/day acceptable, recommends individualized decision-making between 30 and 100 mg/day and recommends against donation above 100 mg/day.

A single abnormal result may need confirmation.

Exercise, infection and other temporary circumstances can influence urine findings. Conversely, repeatedly abnormal results deserve proper investigation rather than being dismissed because the potential donor “feels healthy.”

What if blood is found in the urine?

Persistent microscopic hematuria can have several causes.

Some are relatively benign; others can indicate stones, urinary-tract disease or glomerular kidney disease.

The transplant team may repeat urine testing and investigate the underlying cause before deciding whether donation remains appropriate.

The principle throughout donor evaluation is the same: explain abnormal findings first, then make an eligibility decision.

Blood pressure and kidney donor requirements

Blood pressure has a direct relationship with both cardiovascular and kidney health.

A potential donor with uncontrolled hypertension may have a greater long-term risk after losing renal reserve, particularly when high blood pressure has already caused kidney, heart or vascular damage.

Current OPTN policy requires blood-pressure assessment as part of living donor medical evaluation.

KDIGO recommends measuring blood pressure on at least two occasions using appropriate technique, with ambulatory or standardized repeated measurement when the diagnosis is uncertain. The guideline allows individualized consideration of some candidates whose hypertension is controlled with one or two medications and who have no target-organ damage.

This means two oversimplified statements should both be avoided:

“Anyone taking blood-pressure medication is automatically disqualified.”

and

“Controlled hypertension never matters.”

Neither is universally accurate.

Consider two people.

One is 62, has stable blood pressure controlled on one medication, excellent renal function, no albuminuria and no evidence of cardiovascular damage.

Another is 35, requires several medications, has persistent albuminuria and signs of long-standing hypertension.

The label “hypertension” applies to both, but their predicted donor risk may be very different.

Final assessment therefore belongs to the donor team.

Diabetes, prediabetes and metabolic risk

Diabetes deserves particular attention because it is a major cause of chronic kidney disease.

Our guide to diabetic kidney disease explains how sustained metabolic disease can damage the kidneys. That same relationship is why donor evaluation considers current glucose status and the likelihood of developing diabetes later.

Potential donors may undergo fasting glucose and HbA1c testing, with additional assessment for higher-risk candidates.

OPTN policy requires metabolic assessment, including fasting glucose, and calls for additional testing such as HbA1c or a glucose-tolerance test in certain higher-risk candidates.

A diagnosis of diabetes is not interpreted identically across every jurisdiction or program, but established diabetic complications and high predicted lifetime kidney risk are major concerns.

Prediabetes also deserves attention.

A person who is young, significantly overweight, hypertensive and strongly predisposed to diabetes may have a different long-term risk from an older candidate with a mild isolated glucose abnormality.

Again, the purpose of modern donor assessment is not to turn one laboratory number into a universal verdict. It is to estimate what losing renal reserve could mean for that particular person over time.

Weight, BMI and kidney donation requirements

Body weight is another area where patients often look for one universal cutoff.

There is no single international BMI threshold used by every transplant program.

Obesity matters because it is associated with hypertension, type 2 diabetes, cardiovascular disease and kidney disease. It can also influence surgical risk.

KDIGO recommends calculating BMI and evaluating candidates with obesity individually in relation to their broader health profile and the transplant program's acceptable-risk threshold.

Individual centers may use stricter criteria.

A person with a BMI just above a program's preferred range may sometimes be asked to reduce weight and undergo reassessment. Another candidate may be declined because obesity occurs alongside multiple metabolic risk factors.

This is why “kidney donor weight requirements” should not be reduced to one number without explaining the context.

The transplant team's concern is not appearance or weight alone. It is the interaction between body composition, current metabolic health, surgical safety and future kidney risk.

Kidney stones and recurrent urinary problems

A history of kidney stones does not automatically produce the same decision in every donor.

A single remote stone can have a very different significance from recurrent bilateral stones or an active metabolic stone disorder.

For a person who will be left with one kidney, the team needs to understand whether future stone formation could threaten the remaining kidney.

Current OPTN requirements specify additional 24-hour urine stone testing for certain living kidney donor candidates with a relevant stone history or stones identified on imaging. The assessment includes urinary calcium, oxalate, uric acid, citrate, creatinine and sodium.

Kidney imaging can also reveal stones that the person never knew they had.

Recurrent urinary infections are similarly relevant because they may indicate an underlying anatomical or functional problem.

Neither finding should be hidden because the donor worries it will delay the process.

The purpose of donor evaluation is to determine why the finding exists and whether donation would remain safe.

Family history and inherited kidney disease

Family history can be especially important when the donor and recipient are biologically related.

This creates an interesting paradox.

Being closely related may improve some aspects of immunological compatibility, but it can also mean that the potential donor shares genetic susceptibility to the disease that caused the recipient's kidney failure.

A classic example is polycystic kidney disease, although many other inherited or familial kidney disorders can be relevant.

If a patient developed kidney failure because of a potentially hereditary condition, the transplant team needs to understand whether a sibling, parent or adult child who wants to donate could carry the same risk.

Current OPTN policy requires transplant hospitals to have protocols addressing polycystic kidney disease and other inherited renal disease when family history makes them relevant.

Genetic testing is not automatically appropriate for every donor.

The decision depends on the recipient's diagnosis, family history, the suspected disorder and what the result would mean for the donor.

This is also one reason identifying the recipient's exact cause of kidney failure before donor evaluation is valuable.

If the diagnosis is uncertain, the donor team may need additional information before confidently estimating inherited risk.

Patients can browse our wider transplant-related conditions section to understand how the underlying diagnosis can influence transplant planning.

Cancer history and donor eligibility

Cancer assessment serves two purposes.

First, the transplant team needs to consider whether donation could expose the potential donor to unacceptable future health risk.

Second, it must evaluate whether malignancy could be transmitted to the recipient, whose immune system will be suppressed after transplantation.

A history of cancer therefore requires detail rather than a simple yes/no label.

Important questions include the type of cancer, stage, treatment, time since treatment, recurrence risk, current surveillance and the likelihood that future therapy could affect the donor's remaining kidney.

Current OPTN policy contains exclusion criteria relating to active or incompletely treated malignancy and transmission risk.

A remote low-risk cancer that has been successfully treated may be evaluated differently from active cancer.

Routine age-appropriate cancer screening also forms part of donor assessment.

The correct approach is not for a donor to decide independently that an old diagnosis “doesn't matter.” The transplant team should review it.

Infection screening protects both people

Living donor evaluation includes screening for infections that could affect either the donor's surgical safety or the recipient after transplantation.

This is especially important because transplant recipients require immunosuppressive medication.

The exact infectious-disease panel depends partly on geography, medical history, exposure and current policy.

In the United States, OPTN living-donor requirements were updated again in 2026, including changes to HIV and West Nile virus testing windows and seasonal West Nile virus testing. This illustrates why transplant programs must work from current policy rather than old online checklists.

International donors may require additional assessment based on their country of residence or travel history.

That does not mean they are inherently higher risk.

It means infectious-disease screening should reflect the person's actual epidemiological exposures.

Kidney anatomy: why normal blood tests are not enough

Blood and urine tests cannot show the complete anatomy of the kidneys.

Detailed imaging is therefore required before donor surgery.

The surgeon needs to understand kidney size, arteries, veins, collecting-system anatomy, cysts, stones, masses and other structural differences.

Current OPTN policy requires anatomical assessment to determine whether the kidneys are similar in size, whether masses, cysts, stones or other abnormalities exist and which kidney is anatomically more suitable for transplantation.

This information helps the surgical team decide whether donor nephrectomy is feasible and which kidney should be removed.

The objective is not simply to give the recipient whichever kidney appears easiest to transplant.

Long-term donor welfare remains part of the decision.

If one kidney has a clinically relevant difference and donation can still be considered safely, the team must determine which organ should remain with the donor.

Blood type and compatibility are not the same as donor eligibility

One of the biggest misconceptions in living kidney transplantation is that a matching blood type means the donor has qualified.

It does not.

There are two separate questions:

Is this person medically safe to donate?

Is transplantation between this donor and this recipient immunologically suitable?

Both need satisfactory answers.

A candidate can have excellent health but be difficult to transplant directly into the intended recipient because of immunological incompatibility.

Another candidate can have favorable compatibility but be declined because donation creates excessive health risk.

Blood-group assessment

ABO blood group is an important compatibility factor.

Some donor-recipient blood-group combinations are straightforward, while specialized transplant programs may have protocols for selected incompatible situations.

Whether such an approach is reasonable depends on recipient antibodies, immunological risk, available expertise and local practice.

HLA assessment

Human leukocyte antigen testing provides information about immunologic compatibility.

Close relatives may have more HLA similarities, but successful living kidney transplantation does not require the donor and recipient to be genetically identical.

Spouses and other legally permissible non-biological donors can also be suitable.

Crossmatch testing

Crossmatching assesses whether the recipient has antibodies that react against the proposed donor.

NIDDK explains that donor blood is tested against recipient blood to help predict whether the recipient's immune system is likely to accept or reject the transplanted kidney.

A problematic crossmatch can prevent straightforward direct transplantation even when other aspects look favorable.

The distinction matters when families are planning travel.

A preliminary blood-group match is useful information. It is not an approval letter.

What happens if the potential donor is not a direct match?

Some transplant systems use kidney paired donation or exchange programs when a willing and medically suitable donor cannot donate directly to the intended recipient because of incompatibility.

NHS Blood and Transplant, for example, operates a national living donor kidney-sharing scheme for suitable donor-recipient pairs who cannot proceed directly.

The existence of such programs should not be interpreted as meaning that the same pathway is available internationally.

Paired-exchange systems depend on national law, registry infrastructure, participating transplant centers and specific program rules.

For a person considering transplant treatment abroad, the relevant question is not merely whether paired exchange exists somewhere in the world. It is whether the destination and transplant center can legally and practically offer an appropriate pathway for that specific pair.

Is there an age limit for kidney donation?

Age is important, but one universal upper age limit does not apply everywhere.

Potential donors must have the legal and cognitive capacity to give informed consent. Beyond that, upper-age policies vary.

Physiological health can matter as much as chronological age.

A healthy person in their late 50s or 60s with excellent renal function, normal albumin excretion, favorable blood pressure and low cardiovascular risk may have a different donor profile from a substantially younger person with several long-term risk factors.

However, age changes how long-term risk is interpreted.

For a younger donor, even a modest predisposition to hypertension, diabetes or kidney disease may have many decades in which to develop.

For an older donor, surgical and cardiovascular considerations may carry greater weight.

The transplant program must balance these factors.

Age should therefore be considered as one part of the risk calculation, not as an isolated number taken from a generic internet checklist.

Psychological and psychosocial kidney donor requirements

Psychosocial evaluation is a genuine part of donor eligibility, not administrative paperwork.

Laboratory testing can answer whether kidney function is adequate.

It cannot answer whether the potential donor fully understands the implications of surgery, whether expectations are realistic, whether psychological illness could complicate the process or whether family dynamics are creating inappropriate pressure.

HRSA's current guidance describes psychosocial assessment as part of the living-donor evaluation and specifically addresses decision-making capacity, psychiatric illness and possible coercion.

Financial and practical consequences also matter.

A donor may need time away from work, assistance at home and support during recovery. International donation can add travel and cross-border follow-up considerations.

These issues should be discussed before surgery is scheduled rather than discovered after the family has committed to a treatment date.

Voluntary informed consent is therefore not simply a signed form. It is part of a structured assessment of whether donation is appropriate for that individual.

Pregnancy considerations after kidney donation

Women who may wish to become pregnant after donation need specific counseling.

Living kidney donation does not mean future pregnancy is impossible, and many donors later have healthy pregnancies.

However, the evidence indicates that gestational hypertension and preeclampsia can occur more often after kidney donation than among comparable healthy women who have not donated.

A Canadian cohort reported gestational hypertension or preeclampsia in 15 of 131 post-donation pregnancies, or 11%, compared with 38 of 788 pregnancies, or 5%, among matched healthy nondonors. Most donor pregnancies in the study were uncomplicated, and important fetal outcomes such as preterm birth did not differ significantly.

These numbers should not be used to predict an individual woman's pregnancy outcome.

They are relevant to informed risk counseling.

A donor's previous pregnancy history, including hypertensive pregnancy disorders or gestational diabetes, may also influence assessment.

Future family plans should therefore be discussed openly during donor evaluation.

How safe is living kidney donation?

Living kidney donation has a strong safety record when donors are carefully selected, but “safe” should never be translated into “zero risk.”

Donor nephrectomy is major surgery.

Potential short-term complications include bleeding, infection, blood clots, injury to nearby structures, anesthesia complications and, very rarely, death.

Modern perioperative mortality is low.

A 2024 JAMA national registry study examined living kidney donors in the United States over 30 years. The researchers found that perioperative mortality declined substantially over time and was fewer than one death per 10,000 donations during the most recent decade evaluated.

This is reassuring.

It is also why wording matters.

The correct statement is that surgical mortality is very rare in carefully selected contemporary donors—not that nephrectomy carries no risk.

Patients who want a deeper discussion of donor surgery and long-term safety should ultimately be linked to Day 7, Is Donating a Kidney Safe? Risks and Long-Term Data, once that article is published. Because that Wave 1 spoke is not yet in your sitemap, I have intentionally not created a live link to it here.

Long-term kidney risk after donation

Removing one kidney decreases total renal reserve.

The remaining kidney adapts, and most carefully selected donors maintain sufficient kidney function for normal life.

Nevertheless, long-term risk assessment is important because donation can increase the risk of future kidney failure compared with similarly healthy people who keep both kidneys.

A major JAMA analysis involving 96,217 U.S. living kidney donors estimated 15-year end-stage renal disease risk at 30.8 per 10,000 donors compared with 3.9 per 10,000 matched healthy nondonors. The absolute increase was small, but it was measurable.

These historical cohort numbers should not be interpreted as a personal forecast for someone being assessed in 2026.

Donor-selection standards, surgical practice and population risks evolve.

The clinically useful lesson is narrower: an otherwise healthy person begins with a low risk of kidney failure, but nephrectomy does not make that risk disappear.

This is why long-term risk should be estimated before donation and why follow-up after donation matters.

Why “healthy” does not automatically mean “eligible”

A potential donor may have been told at annual check-ups that they are healthy.

That is encouraging, but donor eligibility uses a different standard.

The transplant team is not merely asking:

“Does this person currently have a disease?”

It is also asking:

“What is likely to happen if this healthy person permanently loses part of their renal reserve?”

That requires greater scrutiny.

A mild risk factor that would normally be managed with routine lifestyle advice could have more significance in someone considering nephrectomy.

For example, borderline blood pressure may be relatively common in the general population. For a living donor candidate, the team may investigate whether it reflects early hypertension, how it behaves outside the clinic and whether other renal or cardiovascular risk factors are present.

The same applies to mild albuminuria, glucose abnormalities, obesity, family history and kidney stones.

Donor screening is deliberately cautious because the person is starting from a position of health.

Findings that may change kidney donor eligibility

Patients often ask for a list of “automatic disqualifications.”

That can be misleading because policies differ between jurisdictions and transplant programs.

A better framework separates findings that usually create major concern from those that may be evaluated individually.

This table is educational rather than a self-screening tool.

An individual result must be interpreted by the transplant team.

The donor evaluation process step by step

Families planning a living donor transplant benefit from understanding the order of evaluation.

Trying to complete everything at once can produce unnecessary costs, duplicate tests and avoidable travel.

Step 1: clarify the recipient's diagnosis and transplant indication

The recipient should first have a clear kidney diagnosis and transplant assessment.

This matters because the cause of kidney failure can affect donor evaluation, especially when inherited disease is possible.

It also prevents a donor from undergoing extensive testing before the recipient's transplant pathway is sufficiently defined.

Step 2: identify the potential donor relationship

The medical team needs basic information about the potential donor.

For an international case, the legal nature of the donor-recipient relationship should also be checked early because different countries use different rules.

A medically excellent potential donor does not automatically satisfy the destination's legal framework.

Step 3: collect existing medical information

Existing laboratory results and medical records can help identify obvious issues before travel or intensive evaluation.

Relevant information may include kidney-function tests, previous urine results, blood-pressure history, medications, previous operations, chronic illnesses, significant infections, cancer history, pregnancy history where relevant and previous kidney imaging.

Our separate guide to documents to prepare for treatment abroad can help families organize records before requesting formal review.

Step 4: preliminary medical review

The transplant center may use available information to decide whether formal donor assessment should continue.

A preliminary review is useful for planning.

It is not equivalent to final approval.

Step 5: complete renal and general health testing

The potential donor undergoes the transplant center's required laboratory, urine and medical assessment.

Abnormal findings may lead to repeat testing or specialist consultation.

Step 6: assess compatibility

Blood group, HLA, recipient antibody profile and crossmatch testing are performed according to the center's protocol.

Compatibility assessment should not be confused with medical eligibility.

Step 7: perform kidney imaging

Anatomical imaging determines whether the kidneys and renal vessels are suitable for donor surgery.

Step 8: complete psychosocial and surgical review

The donor's understanding, motivation, support and psychological suitability are evaluated.

A donor surgeon reviews the proposed nephrectomy and individual surgical risk.

Step 9: complete destination-specific legal evaluation

International cases may have relationship, ethics or administrative requirements beyond the clinical evaluation.

These should be resolved before a final surgery plan is treated as confirmed.

Step 10: multidisciplinary review

Only after the relevant information has been assembled can the transplant program make the final donor decision.

This staged process is more reliable than attempting to label a person “eligible” from a partial set of tests.

How long does the donor evaluation take?

There is no universal donor-evaluation duration.

NIDDK notes that transplant evaluation can involve several visits over weeks to months. Living-donor transplantation has the advantage that surgery can be planned once the donor and recipient are ready rather than waiting for a deceased organ to become available.

For international patients, the timeline may be affected by additional factors.

A clean preliminary medical file may move more efficiently than a case requiring repeated kidney-function testing, genetic assessment, cardiology review or investigation of an unexpected imaging finding.

Legal or ethics review can also influence timing.

Families should therefore avoid purchasing inflexible travel arrangements solely on the basis of an initial health questionnaire.

The medical pathway comes first; definitive travel planning follows the center's instructions.

What documents should a potential donor prepare?

Document preparation serves two different purposes.

One set of documents helps the medical team understand the donor's health.

Another may be required to establish the legal and administrative pathway.

Medical information should be accurate and complete.

It is counterproductive to submit only reassuring laboratory results while leaving out a history of kidney stones, hypertension or another diagnosis because the family worries it may delay approval.

The purpose of preliminary review is to identify those issues early.

Useful health documentation may include previous laboratory reports, medical summaries, medication lists, imaging reports, operation records and details of significant diagnoses.

The recipient's records are also relevant, especially when the cause of kidney failure could be inherited.

For international planning, the destination transplant center should specify exactly which administrative and relationship documents are needed for that case.

Requirements can differ depending on nationality, donor relationship and applicable law.

Our documents to prepare guide provides a broader organizational framework, while the transplant center remains the authority for the case-specific list.

Kidney donor requirements for transplant abroad

Considering transplantation in another country does not reduce the medical standards that should apply to a living donor.

If anything, international planning makes it more important to separate four questions clearly:

Is the recipient medically suitable for transplantation?

Is the potential donor medically suitable to donate?

Are donor and recipient sufficiently compatible for the proposed transplant pathway?

Is the donation legally permissible in the destination?

A “yes” to one does not create a yes to the others.

For example, a patient may have an identified healthy relative with a compatible blood type. That is a promising starting point, but it does not establish kidney function, lifetime donor risk, crossmatch status, kidney anatomy or legal approval.

International patients should therefore evaluate destinations based on the quality of the regulated transplant pathway, not simply the promise of speed.

Our transplant destinations section is designed to help patients compare the country-specific pathway, while the kidney transplant in Turkey page focuses specifically on the Turkish route.

A credible international pathway should also make it clear which decisions belong to the transplant hospital.

A coordinator can help organize records and communication. Donor approval itself is a clinical and regulatory decision made through the transplant program.

This distinction protects both patient and donor.

Kidney donor requirements in Türkiye

For patients considering a kidney transplant in Turkey, medical suitability is only one part of the living-donor pathway.

Türkiye also has specific regulatory rules governing living organ donation.

The Turkish Ministry of Health maintains both the Organ Nakli Hizmetleri Yönetmeliği and a dedicated national clinical protocol titled Böbrek Nakli Canlı Donör Seçimi ve Yaşam Boyu Takip Klinik Protokolü, covering living kidney donor selection and lifelong follow-up. The Ministry's current transplant-services pages continue to list the living-donor kidney protocol as an official clinical resource.

Relationship rules in Türkiye

The Turkish organ-transplant regulation states that living-donor organ transplantation may be performed from the recipient's spouse—generally where the marriage has existed for at least two years—and from blood relatives and relatives by marriage through the fourth degree.

The regulation also provides an exception to the two-year marriage condition when the disease requiring transplantation was diagnosed after the marriage began.

This means relationship status is not simply background information.

It is part of the regulatory assessment.

What happens outside the standard relationship categories?

The regulation provides a separate ethics-review pathway for living-donor transplantation outside the specified spouse and family categories.

Those cases are evaluated by the Organ Nakli Değerlendirme Etik Komisyonu, or Organ Transplant Evaluation Ethics Commission, in the province where the transplant application is made.

The transplant center makes the application and the case is assessed under the regulatory framework.

This is an important distinction for international patients because it prevents the assumption that willingness and medical compatibility alone determine whether transplantation can proceed.

Türkiye regulatory pathway at a glance

The regulation also requires the transplant center to manage the relevant registration and ethics-review process for applicable cases.

Because these rules concern organ-transplant integrity and donor protection, patients should also review Organ Transplant Abroad's ethical sourcing policy when considering any living-donor pathway.

The practical lesson is simple:

Do not treat “healthy donor” and “legally approved donor” as the same thing.

Both need to be established.

Why Türkiye also has a national living kidney donor clinical protocol

A useful feature of the Turkish system is that the Ministry of Health has published a country-specific clinical protocol for living kidney donor selection and lifelong follow-up.

The protocol was developed to provide a nationally applicable clinical framework covering pre-donation medical and surgical evaluation and long-term monitoring of living donors.

For an international patient, this is important for two reasons.

First, it shows that living donor assessment is expected to follow a formal medical process rather than being reduced to blood-group matching.

Second, it reinforces that the donor's long-term health remains relevant after nephrectomy.

When comparing kidney transplant options internationally, patients should therefore look beyond headline surgery dates.

Questions about donor evaluation standards, multidisciplinary review and follow-up are at least as important.

How should patients choose a transplant center for donor evaluation?

A transplant center should be assessed on more than its ability to perform nephrectomy and transplantation.

The quality of the donor pathway matters.

Patients should expect clear separation between donor assessment and recipient treatment goals, structured medical evaluation, qualified transplant specialists, appropriate compatibility testing, formal surgical assessment and compliance with the destination country's legal requirements.

Our current transplant hospitals section provides information about hospitals represented on Organ Transplant Abroad.

Because commercial relationships can create perceived conflicts, patients can also review our partner disclosure to understand how hospital relationships are presented on the platform.

A strong center should be willing to say no when donation would create unacceptable donor risk.

That may be frustrating for a family facing kidney failure, but it is a sign that donor protection is being taken seriously.

Be cautious about interpreting extremely rapid “approval” as automatically superior.

Efficiency is useful.

Skipping evaluation is not.

What happens if the potential donor is declined?

A donor decline does not always mean the same thing.

The most useful next step is to understand the reason.

A temporary or correctable issue

Some findings may require treatment or improvement before reassessment.

Examples can include an acute infection, an unresolved blood-pressure issue or a modifiable metabolic risk.

A finding requiring more investigation

An abnormal urine test, reduced estimated GFR or imaging finding may require confirmation before a final decision.

The initial result is not necessarily the final diagnosis.

A long-term donor-safety concern

Sometimes the medical team concludes that losing renal reserve would create unacceptable future risk.

In that situation, the purpose of the evaluation is being fulfilled by protecting the potential donor.

Immunological incompatibility

A person can be medically suitable to donate yet unsuitable for direct transplantation to the intended recipient.

Depending on the healthcare system, other regulated compatibility pathways may exist.

Legal or ethical ineligibility

In an international case, the proposed donor relationship or circumstances may not fit the standard legal route, or additional ethics review may be required.

These categories should not be mixed together.

A donor who is healthy but incompatible faces a different problem from a donor whose own kidneys are at risk.

Understanding the exact reason determines what, if any, next step is medically appropriate.

Should you seek a second opinion after donor rejection?

In selected cases, a second specialist opinion can be reasonable.

Transplant programs do not always use identical thresholds for every borderline health factor.

However, seeking another opinion should not become “center shopping” for someone willing to ignore a serious donor-safety concern.

The purpose of a second opinion is to clarify uncertainty.

It is not to override important medical risk.

If one center identifies persistent albuminuria, inherited kidney-disease risk or another major concern, that information should be shared completely with any second center.

A responsible transplant decision depends on the whole record.

The financial side of living kidney donor evaluation

Living kidney transplantation involves costs associated with medical evaluation, hospital care, surgery and follow-up.

Those costs must be separated conceptually from the organ itself.

For patients planning treatment internationally, the relevant financial questions include what donor investigations are included, what recipient testing is included, whether additional specialist consultations generate extra charges, what hospital services are covered and what follow-up is provided.

Our kidney transplant surgery cost page is the appropriate place to review current kidney-transplant cost information rather than turning an eligibility article into a price page.

When comparing quotes, patients should ask whether donor assessment is fully represented.

A low headline price can become misleading if essential donor imaging, immunological testing or specialist reviews are excluded.

This is one reason our wider transplant cost information section separates cost questions from clinical eligibility.

The donor should never be treated as an incidental add-on to the recipient's surgery package.

Their evaluation is a separate clinical responsibility.

International travel planning should follow medical review

Families sometimes plan travel in the opposite order.

They first choose dates, book flights and arrange leave from work, then try to complete medical evaluation within that schedule.

A safer approach is to let medical and regulatory readiness determine the travel plan.

Before final arrangements, the transplant center should have enough information to identify whether the potential donor appears appropriate for continued evaluation and what must still be completed after arrival.

This reduces the risk of travelling only to discover an obvious barrier that could have been identified from existing records.

It also reduces psychological pressure on the donor.

Once an entire family has booked travel and organized treatment around one person, the donor may feel that everyone is relying on them.

Good planning avoids creating unnecessary pressure before the transplant team has finished its assessment.

Follow-up is part of donor care, not an optional extra

The living-donor pathway does not end when the donor leaves the hospital.

Kidney function, blood pressure and general health need appropriate follow-up after nephrectomy.

This is particularly important for cross-border care because the donor may return to a different healthcare system after surgery.

Before treatment abroad, the family should understand who will provide early postoperative review, how results will be communicated to the transplant center and what long-term monitoring is recommended.

Türkiye's Ministry of Health living kidney donor protocol explicitly addresses lifelong follow-up as part of the donor-care framework.

International coordination should therefore include a plan for continuity of care, not merely a discharge date.

Patients should also understand that the recipient's follow-up needs are separate and usually more intensive because kidney transplant recipients require immunosuppression and ongoing graft monitoring.

Why living donor transplantation can change the waiting pathway

One major advantage of an approved living kidney donor is the possibility of scheduling transplantation rather than waiting for a deceased donor organ.

NIDDK notes that when a person has a living donor, transplantation can be scheduled in advance once the recipient and donor are ready.

That can be extremely important for patients facing long deceased-donor waiting times.

However, living donation should not be understood as a shortcut around transplant standards.

It changes the source and timing of the organ.

It does not remove the need for recipient evaluation, donor protection, compatibility assessment or legal compliance.

Living-donor kidneys also tend to have strong transplant outcomes.

The OPTN/SRTR 2024 Annual Data Report found that long-term outcomes continued to favor living-donor kidneys in the U.S. data reported. For example, five-year graft survival for transplants performed in 2017–2019 was 89.9% for living-donor kidney recipients aged 18–34 compared with 82.5% for deceased-donor kidney transplantation in that age group. Among recipients aged 65 or older, the respective figures were 79.8% and 66.1%.

Those figures are U.S. registry data, not guaranteed outcomes for an individual patient or hospital.

They help explain why living donation is an important transplant pathway when donor evaluation is performed responsibly.

Questions a potential donor should ask the transplant team

A donor evaluation should be a two-way process.

The transplant team asks questions about the donor's health, but the donor also needs enough information to make an informed decision.

Useful issues to discuss include personal surgical risk, expected renal function after nephrectomy, how the team estimates long-term kidney risk, whether an existing health factor changes that estimate, expected recovery, long-term follow-up and future pregnancy implications where relevant.

The donor can also ask what additional tests would be needed if one result is borderline and how unexpected findings are handled.

In an international case, practical questions matter as well: who is responsible for donor follow-up, how postoperative concerns are communicated and which parts of the evaluation must occur at the transplant center.

An ethical transplant pathway should welcome these questions.

The potential donor is not merely the source of the organ.

They are an independently evaluated patient undergoing major surgery.

Common myths about kidney donor requirements

“If our blood types match, the donor is approved.”

False.

Blood-group compatibility is one component of transplantation. The donor still needs a complete medical, surgical, psychosocial and anatomical evaluation.

“A family member is automatically safer than a non-relative.”

Not necessarily.

Family relationship may help with compatibility, but relatives can share inherited kidney-disease risk.

“Normal creatinine proves someone can donate.”

No.

Kidney donor assessment looks beyond a single creatinine result and may require GFR confirmation, urine testing and imaging.

“Anyone with high blood pressure is disqualified.”

Not universally.

Some carefully selected candidates with well-controlled hypertension and no target-organ damage may be considered under certain guidelines and center policies.

“Being overweight automatically means you cannot donate.”

Not always.

BMI is interpreted alongside metabolic health, blood pressure, diabetes risk, surgical risk and program-specific thresholds.

“Kidney donation is completely risk-free.”

No.

The absolute surgical risk is low in carefully selected donors, but donor nephrectomy is major surgery and long-term kidney risk is not zero.

“A healthy person can donate to anyone in any country.”

No.

Living-donor laws differ between jurisdictions. Türkiye, for example, has specific relationship rules and an ethics-review mechanism for cases outside defined relationship categories.

“A transplant coordinator can guarantee donor approval from medical records.”

No.

Preliminary record review can identify obvious concerns and help organize the pathway, but final donor eligibility belongs to the authorized transplant team after the required evaluation is completed.

What makes a strong potential living kidney donor?

There is no perfect universal donor profile.

A relatively straightforward candidate generally combines several reassuring features.

The person has adequate kidney function, no important urine abnormality, acceptable blood pressure, low metabolic and cardiovascular risk, no major untreated infection, appropriate cancer screening, suitable anatomy and no unresolved inherited kidney-disease concern.

They also understand the operation and its implications and satisfy the applicable psychosocial and legal requirements.

Compatibility with the recipient must then be evaluated separately.

The crucial word is combined.

A potential donor should not be judged from age alone, BMI alone, blood pressure alone, blood type alone or creatinine alone.

The transplant team combines those factors to estimate the overall risk.

This is the principle behind contemporary living donor assessment.

A practical pre-evaluation framework for international patients

Before committing to a living donor transplant abroad, families can organize the case around five questions.

First: Does the recipient have a clear transplant indication?

The diagnosis and transplant need should be established.

Second: Is the potential donor's relationship compatible with the destination's legal pathway?

This should be checked early, especially for Türkiye.

Third: Is there any known donor health information that requires specialist review before travel?

Kidney disease, hypertension, diabetes, stones, major operations, cancer and inherited disease are obvious examples.

Fourth: Has the transplant center identified what evaluation remains necessary?

Preliminary review should not be confused with formal approval.

Fifth: Is there a continuity-of-care plan?

The donor's postoperative and longer-term medical follow-up matters even when the surgery occurs abroad.

This framework does not replace donor evaluation.

Its purpose is to help families ask the right questions in the right order.

Internal resources for planning a living kidney transplant

If you are researching the donor pathway alongside the recipient's treatment, the following parts of Organ Transplant Abroad provide the most relevant next steps.

Start with our kidney transplant procedure guide for the recipient-side transplant pathway.

For destination-specific planning, read Kidney Transplant in Turkey.

For the recipient's underlying diagnosis, browse our conditions library, including diabetic kidney disease and polycystic kidney disease.

For existing records and administrative preparation, use the documents to prepare for treatment abroad guide.

For current financial information, see kidney transplant surgery cost.

Patients comparing providers can review the transplant hospitals section, together with our partner disclosure.

For the principles that govern lawful and ethical transplant coordination on this platform, read the ethical sourcing policy.

These resources answer different parts of the same decision. Donor eligibility should not be collapsed into a hospital choice, price comparison or destination decision.

Final answer: what are the kidney donor requirements?

The essential kidney donor requirements are adequate kidney health, acceptable short- and long-term donor risk, medical fitness for nephrectomy, appropriate urine and metabolic findings, suitable anatomy, infection and cancer assessment, psychosocial suitability, voluntary informed consent and a complete compatibility evaluation with the intended recipient.

No single characteristic determines eligibility.

A person with the right blood type can still be medically unsuitable. A healthy donor can still be incompatible. A medically and immunologically suitable donor can still face destination-specific legal requirements.

For international living kidney transplantation, those three layers—donor safety, donor-recipient compatibility and legal eligibility—need to be evaluated separately.

KDIGO recommends considering the donor's complete health profile rather than relying on isolated risk factors, while current transplant policies and national regulations determine the detailed evaluation requirements that programs must follow.

For patients considering Türkiye, relationship and ethics-review requirements add a regulated legal layer to the medical assessment.

The most useful first objective is therefore not to obtain a quick “yes” from an online checklist. It is to assemble accurate donor and recipient information and allow the authorized transplant team to determine whether formal living donor evaluation can proceed safely.

This article provides a complete overview of kidney donor requirements, explaining who can become a living kidney donor, what medical and psychological evaluations are required, how kidney function and compatibility are assessed, and which health conditions may affect eligibility. It also covers blood pressure, diabetes, body weight, kidney stones, inherited kidney disease, cancer history, infection screening, donor safety, pregnancy considerations, and long-term risks after donation. In addition, the guide explains the difference between being medically suitable and legally eligible, with a dedicated section on kidney donor requirements in Türkiye and the additional rules that apply to international patients considering transplantation abroad.